Dreyfus/The Boston Co Emerg Mkt Cor Eq A
200 Park Avenue New York
Map
Phone: 800-645-6561
| Category: | Diversified Emerging Mkts | | Fund Family: | Dreyfus | | Net Assets: | 30.00K | | Year-to-Date Return: | 59.69% | | Yield: | % | | Morningstar Rating: |  | | Fund Inception Date: | 31-Mar-09 |
|
William S. Patzer
Lead Manager since
07-Aug-07 | | | Patzer is a portfolio manager of Dreyfus and its affiliate, The Boston Company Asset Management LLC. He is also a research analyst covering the health care sector for TBCAM since November 2005. Prior to joining TBCAM, Patzer served as a senior analyst with Goldman Sachs Asset Management. Prior to joining Goldman Sachs, he was a co-manager for the Global Value Fund at Merrill Lynch Investment Managers from 1997 to 2003. Patzer holds the Chartered Financial Analyst designation. |
| Min Initial Investment: | $1,000 | | Min Initial Investment, IRA: | $750 | | Min Initial Investment, AIP: | NaN | | Min Subsequent Investment: | $100 | | Min Subsequent Investment, IRA: | N/A | | Min Subsequent Investment, AIP: | N/A |
|
| |
| The investment seeks long-term growth of capital. The fund invests at least 80% of net assets in equity securities of companies that are located in foreign countries represented in the Morgan Stanley Capital International Emerging Market (MSCI EM) index. It may also enter into equity index futures contracts based primarily on the indices of the countries included in the MSCI EM index and Canada. |
| Last Dividend
| YFT_NOT_APPLICABLE_ABBREVIATION | | Last Cap Gain
| YFT_NOT_APPLICABLE_ABBREVIATION | | Annual Holdings Turnover
| 128.00% | | Average for Category:
| 86.91% |
|
| Expense | DBEAX | Category
Avg | | Total Expense Ratio: | 2.99%
| 1.72% | | Max 12b1 Fee: | %
| N/A | | Max Front End Sales Load: | 5.75%
| 5.55% | | Max Deferred Sales Load: | %
| 2.44% | | 3 Yr Expense Projection*: |
$ 1,446 | $744 | | 5 Yr Expense Projection*: |
$ 2,057 | $1,148 | | 10 Yr Expense Projection*: |
$ 3,693 | $2,315 |
|
|
0.19% Nasdaq 
0.37%
Profile
